STOCK TITAN

CARISMA THERAPEUTICS INC (CARM) Revenue by Year

CARM

CARISMA THERAPEUTICS INC generated $19.6M in revenue in fiscal year 2024. This represents an increase of 31.5% from the prior fiscal year. The table below carries 13 fiscal years, from 2012 to 2024, and the quarters CARISMA THERAPEUTICS INC has filed alongside them.

FY2024 annual
Revenue $19.6M
YoY +31.5%
10Y CAGR +24.2%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CARM Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Revenue$19.6M+31.5%$14.9M+52.0%$9.8M-63.1%$26.5M+136.2%$11.2M$0$0-100.0%$425K+4.7%$406K-17.1%$490K-78.2%$2.2M+68.1%$1.3MN/A

CARM Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Revenue$45.3M+1232.4%N/A$3.7M+8.8%$3.6M-16.3%$3.4M-10.5%$9.2M+155.6%$3.4M+6.3%$4.3M+16.3%$3.8M+47.4%$3.6M+33.2%$3.2M+289.3%$3.7M

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More CARISMA THERAPEUTICS INC financials

Frequently Asked Questions

What was CARISMA THERAPEUTICS INC's revenue in fiscal year 2024?

CARISMA THERAPEUTICS INC generated $19.6M in revenue in fiscal year 2024.

How fast is CARISMA THERAPEUTICS INC's revenue growing?

CARISMA THERAPEUTICS INC (CARM) revenue rose by 31.5% year over year, from $14.9M to $19.6M in fiscal year 2024.

What was CARISMA THERAPEUTICS INC's revenue in the most recent quarter?

CARISMA THERAPEUTICS INC (CARM) reported $45.3M in revenue in Q3 2025. This represents an increase of 1232.4% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what CARISMA THERAPEUTICS INC (CARM) reported on that line in every period on record.